Marc Weiner

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. pmc Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials
    Marc Weiner
    Department of Medicine, University of Texas Health Science Center San Antonio, VAMC, Division of Infectious Diseases 111, 7400 Merton Minter Blvd, San Antonio TX 78229 4404, USA
    J Clin Microbiol 48:4370-6. 2010
  2. pmc Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations
    Marc Weiner
    Division of Infectious Diseases, University of Texas Health Science Center San Antonio and South Texas Veterans Health Care System, San Antonio, Texas 78229 4404, USA
    Antimicrob Agents Chemother 54:4192-200. 2010
  3. pmc Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin
    Marc Weiner
    University of Texas Health Science Center, San Antonio and South Texas Veterans Health Care System, San Antonio, TX 78229 4404, USA
    Antimicrob Agents Chemother 51:2861-6. 2007
  4. ncbi request reprint Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis
    Marc Weiner
    University of Texas Health Science Center San Antonio, TX, USA
    Clin Infect Dis 41:1343-9. 2005
  5. ncbi request reprint Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
    Marc Weiner
    University of Texas Health Science Center San Antonio, South Texas Veterans Health Care System, San Antonio, Texas, USA
    Clin Infect Dis 40:1481-91. 2005
  6. ncbi request reprint Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
    Marc Weiner
    Department of Medicine, South Texas Veterans Health Care System, San Antonio, Texas 78229, USA
    Am J Respir Crit Care Med 169:1191-7. 2004
  7. ncbi request reprint Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
    Marc Weiner
    University of Texas Health Science Center, South Texas Veterans Health Care System, San Antonio 78284, USA
    Am J Respir Crit Care Med 167:1341-7. 2003
  8. ncbi request reprint Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
    William Burman
    Denver Public Health, Denver, CO 80204, USA
    Am J Respir Crit Care Med 173:350-6. 2006
  9. ncbi request reprint Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada
    Lorna Bozeman
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 40:386-91. 2005
  10. ncbi request reprint Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial
    Debra Benator
    Lancet 360:528-34. 2002

Collaborators

Detail Information

Publications12

  1. pmc Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials
    Marc Weiner
    Department of Medicine, University of Texas Health Science Center San Antonio, VAMC, Division of Infectious Diseases 111, 7400 Merton Minter Blvd, San Antonio TX 78229 4404, USA
    J Clin Microbiol 48:4370-6. 2010
    ..Time to detection in an analysis-of-covariance model was associated with lung cavities, less intensive treatment, and differences in the bactericidal effects of treatment regimens...
  2. pmc Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations
    Marc Weiner
    Division of Infectious Diseases, University of Texas Health Science Center San Antonio and South Texas Veterans Health Care System, San Antonio, Texas 78229 4404, USA
    Antimicrob Agents Chemother 54:4192-200. 2010
    ....
  3. pmc Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin
    Marc Weiner
    University of Texas Health Science Center, San Antonio and South Texas Veterans Health Care System, San Antonio, TX 78229 4404, USA
    Antimicrob Agents Chemother 51:2861-6. 2007
    ..Additional studies are required to understand the clinical significance of the moxifloxacin-rifampin interaction...
  4. ncbi request reprint Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis
    Marc Weiner
    University of Texas Health Science Center San Antonio, TX, USA
    Clin Infect Dis 41:1343-9. 2005
    ..To assess this recommendation, rifabutin and efavirenz pharmacokinetic parameters were investigated...
  5. ncbi request reprint Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
    Marc Weiner
    University of Texas Health Science Center San Antonio, South Texas Veterans Health Care System, San Antonio, Texas, USA
    Clin Infect Dis 40:1481-91. 2005
    ..Beyond these associations, the pathogenesis of acquired rifamycin resistance is unknown...
  6. ncbi request reprint Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
    Marc Weiner
    Department of Medicine, South Texas Veterans Health Care System, San Antonio, Texas 78229, USA
    Am J Respir Crit Care Med 169:1191-7. 2004
    ..The present pharmacokinetic study supports further trials to determine the optimal rifapentine dose for treatment of tuberculosis...
  7. ncbi request reprint Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
    Marc Weiner
    University of Texas Health Science Center, South Texas Veterans Health Care System, San Antonio 78284, USA
    Am J Respir Crit Care Med 167:1341-7. 2003
    ....
  8. ncbi request reprint Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
    William Burman
    Denver Public Health, Denver, CO 80204, USA
    Am J Respir Crit Care Med 173:350-6. 2006
    ..Rifabutin was recommended in place of rifampin during treatment of HIV-related tuberculosis (TB) to facilitate concomitant potent antiretroviral therapy, but this approach has not been evaluated in a prospective study...
  9. ncbi request reprint Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada
    Lorna Bozeman
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 40:386-91. 2005
    ....
  10. ncbi request reprint Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial
    Debra Benator
    Lancet 360:528-34. 2002
    ..Rifapentine has a long half-life in serum, which suggests a possible treatment once a week for tuberculosis. We aimed to compare rifapentine and isoniazid once a week with rifampicin and isoniazid twice a week...
  11. ncbi request reprint Stability of antituberculosis drugs mixed in food
    Charles A Peloquin
    Clin Infect Dis 45:521. 2007
  12. doi request reprint Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
    Geoffrey A Block
    Denver Nephrologists, Denver, CO 80230, USA
    Nephrol Dial Transplant 23:2311-8. 2008
    ....